患有毒性休克综合征的患者的长期结果:一项匹配的队列研究
Nathalie Auger1, François M Carrier2, Jason Waechter3
1University of Montreal Hospital Research Centre, Montreal, Quebec, Canada; Institut national de santé publique du Québec, Montreal, Quebec, Canada; Department of Social and Preventive Medicine, School of Public Health, University of Montreal, Montreal, Quebec, Canada; Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, Quebec, Canada.
The Journal of infection
|June 29, 2024
概括
毒性休克综合征 (TSS) 增加了长期再住院的风险,特别是在男性中,因为诸如脏和心脏问题等疾病. 建议对幸存者进行持续的医疗跟踪,以管理潜在的长期健康并发症.
科学领域:
- 传染性疾病 传染性疾病
- 公共卫生 公共卫生
- 临床医学 临床医学
背景情况:
- 毒性休克综合征 (TSS) 是一种严重的,危及生命的疾病.
- 长期TSS的后果并没有得到很好的描述.
- 了解长期结果对于患者管理和公共卫生战略至关重要.
研究的目的:
- 调查与毒性休克综合征相关的长期健康结果和再住院风险.
- 为了比较TSS幸存者的特定发病率与15年期间匹配的对照组.
- 确定受TSS长期并发症影响的风险因素和特定器官系统.
主要方法:
- 从2006年到2021年,在加拿大北克进行了一项匹配的队列研究.
- 630名被诊断为TSS的患者与5009名健康对照人进行了比较.
- 评估的结果包括15年内因脏,心血管和肝脏疾病住院,并计算了调整后的危险比率.
主要成果:
- 患有TSS的男性在15年后,与对照组 (30.0%) 相比,再住院率显著更高 (100%的52.0).
- 患有TSS的女性的再住院率与对照人群相似 (38.7对45.6/100).
- 男性的TSS与脏 (HR 17.43),心血管 (HR 2.57) 和肝脏 (HR 19.83) 住院的风险增加有关. 在女性中,TSS与脏住院有关 (HR 4.71). 链球菌TSS的再住院风险比葡萄球菌TSS更高.
结论:
- 毒性休克综合征与患病后长达15年的特定疾病重新住院的风险增加有关,特别是在男性中.
- 这些发现凸显了TSS后可能导致长期器官损伤和医疗保健利用率增加的可能性.
- 幸存TSS的患者可能会从持续的医疗监测中受益,以减轻长期发病率和改善预后.
相关概念视频
01:26Toxic Reactions: Overview
When toxic substances penetrate the human body, they disseminate to various tissues, undergoing metabolic changes. This process yields reactive metabolites that may covalently bind with specific target molecules, resulting in toxicity.
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
01:21Toxicokinetics: Overview
Studies that assess how a drug is absorbed, distributed, metabolized, and excreted (ADME) at toxic doses are termed toxicokinetics. Understanding toxicokinetics helps predict adverse drug reactions (ADRs) and manage toxicity in humans.Toxicokinetics differs from pharmacokinetics mainly in the dose levels studied, with toxicokinetics focusing on higher toxic doses. The kinetics at these levels can be non-linear due to altered physiological processes. Toxicodynamics examines the relationship...
01:23Toxicity Testing in Animals
Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...
01:30Acute Kidney Injury IV: Diagnostic Studies and Prevention
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...